TriangleNCT04305496 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- other Details
- The Investigator shall be entitled to publish the results of, or make presentations related to, the Study, provided that any publications or presentations to be made within 2 years after completion of the Study shall require the Sponsor's prior written consent.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- limitations And Caveats
- description
- There were 24 participants who were included in both the global cohort and China cohort which gives a total of 818 participants instead of a total of 842 participants.
- point Of Contact
- information.center@astrazeneca.com
- organization
- AstraZeneca
- phone
- 1-877-240-9479
- title
- Global Clinical Lead
Complete source fields
- certain Agreement
- other Details
- The Investigator shall be entitled to publish the results of, or make presentations related to, the Study, provided that any publications or presentations to be made within 2 years after completion of the Study shall require the Sponsor's prior written consent.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- limitations And Caveats
- description
- There were 24 participants who were included in both the global cohort and China cohort which gives a total of 818 participants instead of a total of 842 participants.
- point Of Contact
- information.center@astrazeneca.com
- organization
- AstraZeneca
- phone
- 1-877-240-9479
- title
- Global Clinical Lead
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice